Research from the University of Cincinnati reveals how the MYC oncogene alters PRPS enzymes, impacting redox homeostasis and ...

UC researchers have found how the MYC oncogene fuels lymphoma by altering cell metabolism, paving the way for targeted ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene ...

A study led by University of Cincinnati Cancer Center researchers sheds new light on the mechanisms by which a major oncogene ...

Inobrodib is being developed as a first-in-class oral cancer drug that the company says will be able to treat not only ...

A new review in Genes and Diseases explores the central role of MYC, a master regulatory protein, in the development and progression of cancer, spotlighting its potential as a multidimensional ...

Detailed price information for Monte Rosa Therapeutics Inc (GLUE-Q) from The Globe and Mail including charting and trades.

The predominant signaling pathways leading to dysregulation of translational control in cancer are the PI3K-AKT-mTORC1, RAS-RAF-MAPK, and MYC pathways, which all converge on eukaryotic translation ...

High MYC pathway activity in NC supports ongoing trials targeting ... HN, head and neck; NC, nuclear protein in testis carcinoma; SCC, squamous cell cancer. In summary, to our knowledge, this is the ...

Then, they watched what unfolds in animal models of prostate cancer after MYC activity ramps up. The researchers found that when MYC initially becomes upregulated in precancerous cells, activity ...